Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

MONITORING SARS-COV-2 TRANSMISSION AND PREVALENCE IN POPULATIONS UNDER REPEATED TESTING

Matthew Wascher, Patrick M. Schnell, View ORCID ProfileWasiur R. Khudabukhsh, Mikkel Quam, Joseph H. Tien, View ORCID ProfileGrzegorz A. Rempała
doi: https://doi.org/10.1101/2021.06.22.21259342
Matthew Wascher
1Division of Biostatistics, The Ohio State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick M. Schnell
1Division of Biostatistics, The Ohio State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wasiur R. Khudabukhsh
1Division of Biostatistics, The Ohio State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wasiur R. Khudabukhsh
Mikkel Quam
3Division of Epidemiology, The Ohio State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph H. Tien
2Department of Mathematics, The Ohio State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grzegorz A. Rempała
1Division of Biostatistics, The Ohio State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Grzegorz A. Rempała
  • For correspondence: rempala.3{at}osu.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

We describe a repeat SARS-CoV-2 testing model for monitoring and containing outbreaks in a residential community. The analysis is motivated by the Ohio State University (OSU)’s approach to monitoring disease at its Columbus, Ohio campus during the COVID-19 epidemic in autumn 2020. The model is simple, yet flexible enough to accommodate changes in behavior over time and to eliminate bias due to a nonrandom testing scheme. Model parameters are estimated from individual results of weekly SARS-CoV-2 testing of residents. Model output serves several purposes, including estimating the effective reproduction number and monitoring prevalence to help inform isolation and quarantine bed capacity. An extended version of the model is also considered where the residential population (on-campus students) is assumed to interact with another population for whom the testing regime is more relaxed and possibly less frequent (off-campus students or instructional faculty and staff). To illustrate the model application, we analyze both the synthetic data as well as the actual student SARS-CoV-2 testing data collected at OSU Columbus campus.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

MW was supported by NSF RAPID Grant DMS-2027001. WRK was supported by the President Postdoctoral Scholars Program (PPSP) of the Ohio State university. GAR was supported by NSF RAPID Grant DMS-2027001 and NSF Grant DMS- 1853587. PMS was supported by the NIH Grant UL1TR002733. The authors are grateful to Yuhan Pan, Namrata Banerji, Steve Chang, Ron Davies, and Tanya Berger-Wolf for support with data acquisition and cleaning. This project was partially supported by the Ohio State University's Comprehensive Monitoring Team

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The student testing data for adults only (students 18 years old or older at the time of first testing) were de-identified and extracted from The Ohio State University operational screening for SARS-CoV-2 under research protocol 2021H0189, approved by The Ohio State University Institutional Review Board.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* wascher.1{at}osu.edu;

  • ↵† schnell.31{at}osu.edu;

  • ↵‡ khudabukhsh.2{at}osu.edu;

  • tien.20{at}osu.edu

  • ↵¶ quam.7{at}osu.edu

Data Availability

All datasets from Sec 3.3-4 considered in the paper, along with an additional synthetic dataset inspired by the OSU student testing data and the python implementation of the parameter estimation algorithms, are provided at the link below.

https://github.com/mwwascher/IDSA

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 25, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
MONITORING SARS-COV-2 TRANSMISSION AND PREVALENCE IN POPULATIONS UNDER REPEATED TESTING
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
MONITORING SARS-COV-2 TRANSMISSION AND PREVALENCE IN POPULATIONS UNDER REPEATED TESTING
Matthew Wascher, Patrick M. Schnell, Wasiur R. Khudabukhsh, Mikkel Quam, Joseph H. Tien, Grzegorz A. Rempała
medRxiv 2021.06.22.21259342; doi: https://doi.org/10.1101/2021.06.22.21259342
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
MONITORING SARS-COV-2 TRANSMISSION AND PREVALENCE IN POPULATIONS UNDER REPEATED TESTING
Matthew Wascher, Patrick M. Schnell, Wasiur R. Khudabukhsh, Mikkel Quam, Joseph H. Tien, Grzegorz A. Rempała
medRxiv 2021.06.22.21259342; doi: https://doi.org/10.1101/2021.06.22.21259342

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (576)
  • Allergy and Immunology (868)
  • Anesthesia (306)
  • Cardiovascular Medicine (4482)
  • Dentistry and Oral Medicine (449)
  • Dermatology (385)
  • Emergency Medicine (615)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1528)
  • Epidemiology (15278)
  • Forensic Medicine (31)
  • Gastroenterology (1133)
  • Genetic and Genomic Medicine (6645)
  • Geriatric Medicine (671)
  • Health Economics (1006)
  • Health Informatics (4605)
  • Health Policy (1378)
  • Health Systems and Quality Improvement (1623)
  • Hematology (544)
  • HIV/AIDS (1276)
  • Infectious Diseases (except HIV/AIDS) (15961)
  • Intensive Care and Critical Care Medicine (1111)
  • Medical Education (626)
  • Medical Ethics (147)
  • Nephrology (674)
  • Neurology (6695)
  • Nursing (346)
  • Nutrition (1006)
  • Obstetrics and Gynecology (1153)
  • Occupational and Environmental Health (961)
  • Oncology (3369)
  • Ophthalmology (988)
  • Orthopedics (370)
  • Otolaryngology (421)
  • Pain Medicine (437)
  • Palliative Medicine (131)
  • Pathology (669)
  • Pediatrics (1704)
  • Pharmacology and Therapeutics (700)
  • Primary Care Research (717)
  • Psychiatry and Clinical Psychology (5495)
  • Public and Global Health (9285)
  • Radiology and Imaging (2223)
  • Rehabilitation Medicine and Physical Therapy (1375)
  • Respiratory Medicine (1201)
  • Rheumatology (598)
  • Sexual and Reproductive Health (721)
  • Sports Medicine (535)
  • Surgery (722)
  • Toxicology (100)
  • Transplantation (290)
  • Urology (267)